(Q52544199)

3 May 2018

title

A potential autocrine pathway for growth hormone releasing hormone (GHRH) and its receptor in human prostate cancer cell lines. (English)

1 reference

3 May 2018

author

Adrian C. Herington

series ordinal

2

1 reference

3 May 2018

author name string

Chopin LK

series ordinal

1

1 reference

3 May 2018

publication date

1 October 2001

1 reference

3 May 2018

published in

The Prostate

1 reference

3 May 2018

volume

49

1 reference

3 May 2018

issue

2

1 reference

3 May 2018

page(s)

116-121

1 reference

3 May 2018

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

cites work

1 reference

Decrease in telomerase activity in U-87MG human glioblastomas after treatment with an antagonist of growth hormone-releasing hormone.

21 January 2018

1 reference

Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways

21 January 2018

1 reference

Growth hormone-releasing hormone: an autocrine growth factor for small cell lung carcinoma.

21 January 2018

1 reference

Antitumorigenic actions of growth hormone-releasing hormone antagonists

21 January 2018

1 reference

Inhibition of in vivo proliferation of androgen-independent prostate cancers by an antagonist of growth hormone-releasing hormone

21 January 2018

1 reference

Growth hormone-releasing hormone antagonist MZ-5-156 inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of insulin-like growth factor II in tumors

21 January 2018

1 reference

Inhibition of growth, production of insulin-like growth factor-II (IGF-II), and expression of IGF-II mRNA of human cancer cell lines by antagonistic analogs of growth hormone-releasing hormone in vitro

21 January 2018

1 reference

Antagonistic analogs of growth hormone releasing hormone (GHRH) inhibit cyclic AMP production of human cancer cell lines in vitro

21 January 2018

1 reference

Antagonistic actions of analogs related to growth hormone-releasing hormone (GHRH) on receptors for GHRH and vasoactive intestinal peptide on rat pituitary and pineal cells in vitro

21 January 2018

1 reference

Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers.

21 January 2018

1 reference

Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone

21 January 2018

1 reference

Tissue-specific molecular heterogeneity of human growth hormone-releasing hormone receptor protein.

21 January 2018

1 reference

Characterization of ALVA-41 cells, a new human prostatic cancer cell line

21 January 2018

1 reference

Inhibition of signal transduction by a splice variant of the growth hormone-releasing hormone receptor expressed in human pituitary adenomas

21 January 2018

1 reference

Expression-cloning and sequence of a cDNA encoding human growth hormone-releasing factor

21 January 2018

1 reference

Receptors for secretin, calcitonin, parathyroid hormone (PTH)/PTH-related peptide, vasoactive intestinal peptide, glucagonlike peptide 1, growth hormone-releasing hormone, and glucagon belong to a newly discovered G-protein-linked receptor family

21 January 2018

1 reference

Immunohistological Localization of Growth Hormone-Releasing Hormone in Human Tumors*

21 January 2018

1 reference

Serum insulin-like growth factor-1 is not a useful marker of prostate cancer

21 January 2018

1 reference

Growth hormone directly affects the function of the different lobes of the rat prostate

21 January 2018

1 reference

Antagonistic Analogs of Growth Hormone-releasing Hormone: New Potential Antitumor Agents

21 January 2018

1 reference

Type 1 vasoactive intestinal peptide receptor expression in PC3/AR cells is evidence of prostate epithelial differentiation

21 January 2018

1 reference

Antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide inhibit tumor proliferation by different mechanisms: evidence from in vitro studies on human prostatic and pancreatic cancers

21 January 2018

1 reference

Presence of growth hormone-releasing hormone-like immunoreactivity in human tumors: characterization of immunological and biological properties

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PROS.1125

1 reference

3 May 2018

1 reference

3 May 2018